Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Market Cap 172 millions only?

<< Previous

Bullboard Posts

Next >>

Comment by stockbuphoonon Jun 07, 2021 10:01am

86 Views

Post# 33339441

RE:Market Cap 172 millions only?

StockReddy, what indication/ associated markets are you basing your price target on? Cash is just going to burn and what is the next trial and when could anything get to market or even to partner capability?